31 research outputs found
Impact of uterine manipulator on oncological outcome in endometrial cancer surgery
Background: There are limited data available to indicate whether oncological outcomes might be influenced by the uterine manipulator, which is used at the time of hysterectomy for minimally invasive surgery in patients with endometrial cancer. The current evidence derives from retrospective studies with limited sample sizes. Without substantial evidence to support its use, surgeons are required to make decisions about its use based only on their personal choice and surgical experience.
Objective: To evaluate the use of the uterine manipulator on oncological outcomes after minimally invasive surgery, for apparent early-stage endometrial cancer. Study Design: We performed a retrospective multicentric study to assess the oncological safety of uterine manipulator use in patients with apparent early-stage endometrial cancer, treated with minimally invasive surgery. The type of manipulator, surgical staging, histology, lymphovascular space invasion, International Federation of Gynecology and Obstetrics stage, adjuvant treatment, recurrence, and pattern of recurrence were evaluated. The primary objective was to determine the relapse rate. The secondary objective was to determine recurrence-free survival, overall survival, and the pattern of recurrence.
Results: A total of 2661 women from 15 centers were included; 1756 patients underwent hysterectomy with a uterine manipulator and 905 without it. Both groups were balanced with respect to histology, tumor grade, myometrial invasion, International Federation of Gynecology and Obstetrics stage, and adjuvant therapy. The rate of recurrence was 11.69% in the uterine manipulator group and 7.4% in the no-manipulator group (P<.001). The use of the uterine manipulator was associated with a higher risk of recurrence (hazard ratio, 2.31; 95% confidence interval, 1.27–4.20; P=.006). The use of uterine manipulator in uterus-confined endometrial cancer (International Federation of Gynecology and Obstetrics [FIGO] I–II) was associated with lower disease-free survival (hazard ratio, 1.74; 95% confidence interval, 0.57–0.97; P=.027) and higher risk of death (hazard ratio, 1.74; 95% confidence interval, 1.07–2.83; P=.026). No differences were found regarding the pattern of recurrence between both groups (chi-square statistic, 1.74; P=.63).
Conclusion: In this study, the use of a uterine manipulator was associated with a worse oncological outcome in patients with uterus-confined endometrial cancer (International Federation of Gynecology and Obstetrics I–II) who underwent minimally invasive surgery. Prospective trials are essential to confirm these results
One-step nucleic acid amplification (Osna) of sentinel lymph node in early-stage endometrial cancer: Spanish multicenter study (endo-osna)
The objective of this study was to evaluate the efficacy of one-step nucleic acid amplification (OSNA) for the detection of sentinel lymph node (SLN) metastasis compared to standard pathological ultrastaging in patients with early-stage endometrial cancer (EC). A total of 526 SLNs from 191 patients with EC were included in the study, and 379 SLNs (147 patients) were evaluated by both methods, OSNA and standard pathological ultrastaging. The central 1 mm portion of each lymph node was subjected to semi-serial sectioning at 200 µm intervals and examined by hematoxylin–eosin and immunohistochemistry with CK19; the remaining tissue was analyzed by OSNA for CK19 mRNA. The OSNA assay detected metastases in 19.7% of patients (14.9% micrometastasis and 4.8% macrometastasis), whereas pathological ultrastaging detected metastasis in 8.8% of patients (3.4% micrometastasis and 5.4% macrometastasis). Using the established cut-off value for detecting SLN metastasis by OSNA in EC (250 copies/µL), the sensitivity of the OSNA assay was 92%, specificity was 82%, diagnostic accuracy was 83%, and the negative predictive value was 99%. Discordant results between both methods were recorded in 20 patients (13.6%). OSNA resulted in an upstaging in 12 patients (8.2%). OSNA could aid in the identification of patients requiring adjuvant treatment at the time of diagnosis. © 2021 by the authors. Licensee MDPI, Basel, Switzerland
Antikinetoplastid SAR study in 3-nitroimidazopyridine series: identification of a novel non-genotoxic and potent anti-T. b. brucei hit-compound with improved pharmacokinetic properties
To study the antikinetoplastid 3-nitroimidazo[1,2-a]pyridine pharmacophore, a structure-activity relationship study was conducted through the synthesis of 26 original derivatives and their in vitro evaluation on both Leishmania spp and Trypanosoma brucei brucei. This SAR study showed that the antitrypanosomal pharmacophore was less restrictive than the antileishmanial one and highlighted positions 2, 6 and 8 of the imidazopyridine ring as key modulation points. None of the synthesized compounds allowed improvement in antileishmanial activity, compared to previous hit molecules in the series. Nevertheless, compound 8, the best antitrypanosomal molecule in this series (EC50 = 17 nM, SI = 2650 & E° = -0.6 V), was not only more active than all reference drugs and previous hit molecules in the series but also displayed improved aqueous solubility and better in vitro pharmacokinetic characteristics: good microsomal stability (T1/2 > 40 min), moderate albumin binding (77%) and moderate permeability across the blood brain barrier according to a PAMPA assay. Moreover, both micronucleus and comet assays showed that nitroaromatic molecule 8 was not genotoxic in vitro. It was evidenced that bioactivation of molecule 8 was operated by T. b. brucei type 1 nitroreductase, in the same manner as fexinidazole. Finally, a mouse pharmacokinetic study showed that 8 displayed good systemic exposure after both single and repeated oral administrations at 100 mg/kg (NOAEL) and satisfying plasmatic half-life (T1/2 = 7.7 h). Thus, molecule 8 appears as a good candidate for initiating a hit to lead drug discovery program
Novel, technical advance: a new grapevine transpiration prototype for grape berries and whole bunch based on relative humidity sensors
Grape berry transpiration is considered an important process during maturation, but scientific evidence is scarce. In the literature, there is only one report showing reduced maturation when bunch transpiration is artificially slowed down. Traditionally, grape berry transpiration has been measured by weighing grape berries on scale for a given time, correctly assuming that the weight reduction is due to water lost. Commercially available instruments adequate to measure gas exchange in small fruits are not suitable for whole grape berry bunch.
Here, we present an open differential chamber system that can be used with isolated grape berries or alternatively with a whole grape berry bunch for measuring grape berry/bunch transpiration based on the use of relative humidity sensors from Vaisala.
When used with isolated grape berries, open differential chamber system validation was made by using Tempranillo grape berries collected at different phenological stages. For the whole bunch transpiration prototype, two different validations were made. Firstly, measurements were made inserting inside the chamber an increasing number of Eppendorf tubes filled with water. Secondly, transpiration was measured in whole Tempranillo bunches sampled at different phenological stages. An important output of this work is that the fact of detaching the bunch from the plant did not change the bunch gas exchange rates at least for several hours
A quick assessment of topology preservation for SOM structures.
Several topology preservation measures and monitoring schemes have been proposed to help ascertain the correct organization of the self-organizing map (SOM) structure. Here, we consider a novel idea that performs faster than previous alternatives while showing interesting behavior in practice. Our proposal aims to facilitate inexpensive, online monitoring of topographic map formation algorithms
A quick assessment of topology preservation for SOM structures.
Several topology preservation measures and monitoring schemes have been proposed to help ascertain the correct organization of the self-organizing map (SOM) structure. Here, we consider a novel idea that performs faster than previous alternatives while showing interesting behavior in practice. Our proposal aims to facilitate inexpensive, online monitoring of topographic map formation algorithms
SOMwise regression: A new clusterwise regression method
We present a novel neural learning architecture for regression data analysis. It combines, at the high level, a self-organizing map (SOM) structure, and, at the low level, a multilayer perceptron at each unit of the SOM structure. The goal is to build a clusterwise regression model, that is, a model recognizing several clusters in the data, where the dependence between predictors and response is variable (typically within some parametric range) from cluster to cluster. The proposed algorithm, called SOMwise Regression, follows closely in the spirit of the standard SOM learning algorithm and has performed satisfactorily on various test problems. © 2011 Springer-Verlag London Limited
Validation of the in vitro comet assay for DNA cross‑links and altered bases detection
Mechanistic toxicology is gaining weight for human health risk assessment. Different mechanistic assays are available, such
as the comet assay, which detects DNA damage at the level of individual cells. However, the conventional alkaline version
only detects strand breaks and alkali-labile sites. We have validated two modifications of the in vitro assay to generate mechanistic
information: (1) use of DNA-repair enzymes (i.e., formamidopyrimidine DNA glycosylase, endonuclease III, human
8-oxoguanine DNA glycosylase I and human alkyladenine DNA glycosylase) for detection of oxidized and alkylated bases
as well as (2) a modification for detecting cross-links. Seven genotoxicants with different mechanisms of action (potassium
bromate, methyl methanesulfonate, ethyl methanesulfonate, hydrogen peroxide, cisplatin, mitomycin C, and benzo[a]pyrene
diol epoxide), as well as a non-genotoxic compound (dimethyl sulfoxide) and a cytotoxic compound (Triton X-100) were
tested on TK-6 cells. We were able to detect with high sensitivity and clearly differentiate oxidizing, alkylating and crosslinking
agents. These modifications of the comet assay significantly increase its sensitivity and its specificity towards DNA
lesions, providing mechanistic information regarding the type of damage